Global Radioactive Stents Market Research Report 2024
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Retrograde Stents
Antegrade Stents
Internal (Double-J) Stents
Iodine-125 Radioactive Stents
Others
Segment by Application
Lithotripsy
Ureteroscopy
Ureteroenoscopy
Percutaneous Nephrolithotomy
Angiography
Neointimal Hyperplasia
Esophageal Cancer
Biliary Cancer
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
C.R. Bard, Inc.
Cook Medical Inc.
Medline Industries Ltd
Pnn Medical A/S
Allium Medical Solutions Ltd.
APC Cardiovascular Ltd.
Micro-Tech Pvt. Ltd.
Changzhou Zhiye Co Ltd.
Aetna Inc.
Abbott Laboratories

Table of Content
1 Radioactive Stents Market Overview
1.1 Product Overview and Scope of Radioactive Stents
1.2 Radioactive Stents Segment by Type
1.2.1 Global Radioactive Stents Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Retrograde Stents
1.2.3 Antegrade Stents
1.2.4 Internal (Double-J) Stents
1.2.5 Iodine-125 Radioactive Stents
1.2.6 Others
1.3 Radioactive Stents Segment by Application
1.3.1 Global Radioactive Stents Sales Comparison by Application: (2021-2027)
1.3.2 Lithotripsy
1.3.3 Ureteroscopy
1.3.4 Ureteroenoscopy
1.3.5 Percutaneous Nephrolithotomy
1.3.6 Angiography
1.3.7 Neointimal Hyperplasia
1.3.8 Esophageal Cancer
1.3.9 Biliary Cancer
1.3.10 Others
1.4 Global Radioactive Stents Market Size Estimates and Forecasts
1.4.1 Global Radioactive Stents Revenue 2016-2027
1.4.2 Global Radioactive Stents Sales 2016-2027
1.4.3 Radioactive Stents Market Size by Region: 2016 Versus 2021 Versus 2027
2 Radioactive Stents Market Competition by Manufacturers
2.1 Global Radioactive Stents Sales Market Share by Manufacturers (2016-2021)
2.2 Global Radioactive Stents Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Radioactive Stents Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Radioactive Stents Manufacturing Sites, Area Served, Product Type
2.5 Radioactive Stents Market Competitive Situation and Trends
2.5.1 Radioactive Stents Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Radioactive Stents Players Market Share by Revenue
2.5.3 Global Radioactive Stents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Radioactive Stents Retrospective Market Scenario by Region
3.1 Global Radioactive Stents Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Radioactive Stents Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Radioactive Stents Market Facts & Figures by Country
3.3.1 North America Radioactive Stents Sales by Country
3.3.2 North America Radioactive Stents Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Radioactive Stents Market Facts & Figures by Country
3.4.1 Europe Radioactive Stents Sales by Country
3.4.2 Europe Radioactive Stents Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Radioactive Stents Market Facts & Figures by Region
3.5.1 Asia Pacific Radioactive Stents Sales by Region
3.5.2 Asia Pacific Radioactive Stents Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Radioactive Stents Market Facts & Figures by Country
3.6.1 Latin America Radioactive Stents Sales by Country
3.6.2 Latin America Radioactive Stents Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Radioactive Stents Market Facts & Figures by Country
3.7.1 Middle East and Africa Radioactive Stents Sales by Country
3.7.2 Middle East and Africa Radioactive Stents Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Radioactive Stents Historic Market Analysis by Type
4.1 Global Radioactive Stents Sales Market Share by Type (2016-2021)
4.2 Global Radioactive Stents Revenue Market Share by Type (2016-2021)
4.3 Global Radioactive Stents Price by Type (2016-2021)
5 Global Radioactive Stents Historic Market Analysis by Application
5.1 Global Radioactive Stents Sales Market Share by Application (2016-2021)
5.2 Global Radioactive Stents Revenue Market Share by Application (2016-2021)
5.3 Global Radioactive Stents Price by Application (2016-2021)
6 Key Companies Profiled
6.1 C.R. Bard, Inc.
6.1.1 C.R. Bard, Inc. Corporation Information
6.1.2 C.R. Bard, Inc. Description and Business Overview
6.1.3 C.R. Bard, Inc. Radioactive Stents Sales, Revenue and Gross Margin (2016-2021)
6.1.4 C.R. Bard, Inc. Radioactive Stents Product Portfolio
6.1.5 C.R. Bard, Inc. Recent Developments/Updates
6.2 Cook Medical Inc.
6.2.1 Cook Medical Inc. Corporation Information
6.2.2 Cook Medical Inc. Description and Business Overview
6.2.3 Cook Medical Inc. Radioactive Stents Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Cook Medical Inc. Radioactive Stents Product Portfolio
6.2.5 Cook Medical Inc. Recent Developments/Updates
6.3 Medline Industries Ltd
6.3.1 Medline Industries Ltd Corporation Information
6.3.2 Medline Industries Ltd Description and Business Overview
6.3.3 Medline Industries Ltd Radioactive Stents Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Medline Industries Ltd Radioactive Stents Product Portfolio
6.3.5 Medline Industries Ltd Recent Developments/Updates
6.4 Pnn Medical A/S
6.4.1 Pnn Medical A/S Corporation Information
6.4.2 Pnn Medical A/S Description and Business Overview
6.4.3 Pnn Medical A/S Radioactive Stents Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Pnn Medical A/S Radioactive Stents Product Portfolio
6.4.5 Pnn Medical A/S Recent Developments/Updates
6.5 Allium Medical Solutions Ltd.
6.5.1 Allium Medical Solutions Ltd. Corporation Information
6.5.2 Allium Medical Solutions Ltd. Description and Business Overview
6.5.3 Allium Medical Solutions Ltd. Radioactive Stents Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Allium Medical Solutions Ltd. Radioactive Stents Product Portfolio
6.5.5 Allium Medical Solutions Ltd. Recent Developments/Updates
6.6 APC Cardiovascular Ltd.
6.6.1 APC Cardiovascular Ltd. Corporation Information
6.6.2 APC Cardiovascular Ltd. Description and Business Overview
6.6.3 APC Cardiovascular Ltd. Radioactive Stents Sales, Revenue and Gross Margin (2016-2021)
6.6.4 APC Cardiovascular Ltd. Radioactive Stents Product Portfolio
6.6.5 APC Cardiovascular Ltd. Recent Developments/Updates
6.7 Micro-Tech Pvt. Ltd.
6.6.1 Micro-Tech Pvt. Ltd. Corporation Information
6.6.2 Micro-Tech Pvt. Ltd. Description and Business Overview
6.6.3 Micro-Tech Pvt. Ltd. Radioactive Stents Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Micro-Tech Pvt. Ltd. Radioactive Stents Product Portfolio
6.7.5 Micro-Tech Pvt. Ltd. Recent Developments/Updates
6.8 Changzhou Zhiye Co Ltd.
6.8.1 Changzhou Zhiye Co Ltd. Corporation Information
6.8.2 Changzhou Zhiye Co Ltd. Description and Business Overview
6.8.3 Changzhou Zhiye Co Ltd. Radioactive Stents Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Changzhou Zhiye Co Ltd. Radioactive Stents Product Portfolio
6.8.5 Changzhou Zhiye Co Ltd. Recent Developments/Updates
6.9 Aetna Inc.
6.9.1 Aetna Inc. Corporation Information
6.9.2 Aetna Inc. Description and Business Overview
6.9.3 Aetna Inc. Radioactive Stents Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Aetna Inc. Radioactive Stents Product Portfolio
6.9.5 Aetna Inc. Recent Developments/Updates
6.10 Abbott Laboratories
6.10.1 Abbott Laboratories Corporation Information
6.10.2 Abbott Laboratories Description and Business Overview
6.10.3 Abbott Laboratories Radioactive Stents Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Abbott Laboratories Radioactive Stents Product Portfolio
6.10.5 Abbott Laboratories Recent Developments/Updates
7 Radioactive Stents Manufacturing Cost Analysis
7.1 Radioactive Stents Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Radioactive Stents
7.4 Radioactive Stents Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Radioactive Stents Distributors List
8.3 Radioactive Stents Customers
9 Radioactive Stents Market Dynamics
9.1 Radioactive Stents Industry Trends
9.2 Radioactive Stents Growth Drivers
9.3 Radioactive Stents Market Challenges
9.4 Radioactive Stents Market Restraints
10 Global Market Forecast
10.1 Radioactive Stents Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Radioactive Stents by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Radioactive Stents by Type (2022-2027)
10.2 Radioactive Stents Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Radioactive Stents by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Radioactive Stents by Application (2022-2027)
10.3 Radioactive Stents Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Radioactive Stents by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Radioactive Stents by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer